COMMUNIQUÉS West-GlobeNewswire

ImmuCell Announces Bank Debt Refinancing
12/08/2025
PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]
Solid Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Updates
12/08/2025
- Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to discuss regulatory pathways with U.S. FDA in Q4 2025 - - FA (SGT-212): Phase 1b trial [...]
PetMed Express, Inc. Announces Management Changes
12/08/2025
DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced that its Chief Executive Officer, Sandra Campos, and [...]
First Lady Anna Stein, NCDHHS and Morse Clinics Celebrate First Mobile Opioid Treatment Program Unit in North Carolina
12/08/2025
Raleigh, NC, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Credentialed media are invited to attend the unveiling of the first Mobile Opioid Treatment Program (OTP) unit in North Carolina. Mobile OTPs reduce barriers to [...]
Sienna Reports Second Quarter 2025 Financial Results and Publishes 2025 Impact Report
12/08/2025
MARKHAM, Ontario, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced its financial results for the three and six months ended June 30, 2025. Highlights [...]
vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
12/08/2025
• First study participant randomized in Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes with data expected in second half of 2026 • Cadisegliatin intellectual property portfolio [...]
Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
12/08/2025
Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in H2 2026 Announced positive data from Phase 1b/2a RESOLVE supporting the potential of [...]
Maximus Ranks No. 27 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
12/08/2025
With Three-Year Revenue Growth of 7260.85%, This Marks Maximus' 1st Time on the List Los Angeles, CA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business [...]
HealthEx Launches Platform to Empower Patients with Real-time Health Record Access in Collaboration with Industry Leaders
12/08/2025
New platform delivers on CMS vision and industry’s urgent need for end-to-end health data interoperability and a patient-centric healthcare ecosystem HealthEx leads a cross-industry effort with athenahealth, CLEAR, [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
12/08/2025
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 12 août 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 32 - 2025
12/08/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 04 août au 08 août 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2025
12/08/2025
Aggregated presentation by day and by market Statement of transactions in own shares from August 4th to August 8th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
Compass Health announces completion of first-ever capital campaign to fund state-of-the-art facility for intensive behavioral health services
12/08/2025
The campaign supported the construction of the Marc Healing Center, Phase II of Compass Health’s Broadway Campus Redevelopment EVERETT, Wash., Aug. 12, 2025 (GLOBE NEWSWIRE) -- When Compass Health set out to build a [...]
Birches Health, a leading clinical provider of Gambling Addiction care, expands statewide access to specialized Problem Gambling treatment across Nevada
12/08/2025
LAS VEGAS, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Using funding from the Nevada Division of Public and Behavioral Health (DPBH), Birches Health today launched a groundbreaking program focused on expanding access to evidence- [...]
TRYVIO nominated for the 2025 Prix Galien USA “Best Pharmaceutical Product”
12/08/2025
Allschwil, Switzerland – August 12, 2025 Idorsia Ltd (SIX: IDIA) announced today that The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, has nominated TRYVIO™ ( [...]
MedTech Manufacturer Juvent Joins the Inc. 5000 List of America’s Fastest-Growing Private Companies
12/08/2025
With Three-Year Revenue Growth of 552%, This Marks Juvent’s First Time on the List CHATTANOOGA, Tenn., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business [...]
Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update
12/08/2025
Commenced site activation for REVEAL pivotal trial in accordance with previously aligned upon key design elements, following receipt of No Objection Letter (NOL) from Health Canada and feedback from the FDA; patient [...]
Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
12/08/2025
Secured over $111 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by over $71 million in committed capital from Medtronic [...]
Biotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14th
12/08/2025
Company to announce continued Revenue Growth, Improvements in Margins, Operational Efficiency, and a shift to positive EBITDA REDWOOD CITY, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an [...]

Pages